Invasive Fungal Infection
📧 Sign up to get email alerts when something new happens for Invasive Fungal Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection [Phase 3]
Phase 3 pharmacokinetic study of the itraconazole oral solution JK1211 (Itrizole) in patients with invasive fungal infections; results have …
-
CLINICAL_TRIALS trial_result · 2011-12-09Clinical Trial Update: Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems [Phase 2]
Phase 2 trial evaluating voriconazole plus caspofungin acetate for invasive fungal infections in immunocompromised adults; the study was ter…
-
CLINICAL_TRIALS trial_result · 2011-10-14Clinical Trial Update: Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection [Phase 4]
Phase 4 clinical trial evaluating itraconazole as secondary prophylaxis for invasive fungal infection in patients undergoing allogeneic stem…
-
CLINICAL_TRIALS trial_result · 2011-09-13Clinical Trial Update: Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED) [Phase 3]
A Phase 3 trial comparing posaconazole to fluconazole for prevention of invasive fungal infections in leukopenic patients has completed, wit…
-
CLINICAL_TRIALS trial_result · 2011-04-29Clinical Trial Update: Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551) [Phase 3]
Phase 3 trial results for posaconazole in invasive fungal infection were reported by Merck Sharp & Dohme LLC. The study status is completed …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea
Pfizer conducted a non-interventional post-marketing study in Korea to observe the safety and efficacy of Vfend (voriconazole) tablets for s…
-
CLINICAL_TRIALS trial_result · 2010-08-18Clinical Trial Update: Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients [Phase 3]
Phase 3 trial comparing immediate versus deferred empirical voriconazole therapy in neutropenic patients at risk for fungal infection; resul…
-
CLINICAL_TRIALS trial_result · 2009-09-22Clinical Trial Update: Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641)
A post-marketing surveillance study of posaconazole for invasive mycoses has completed and posted its results.
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Antifungal Use in Oncohematological Neutropenic Patients [Phase 4]
This Phase 4 clinical trial update reports results on antifungal use in neutropenic patients with oncohematological conditions to address in…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections [Phase 3]
This Phase 3 trial update discusses the emergency use of voriconazole for life-threatening invasive fungal infections and indicates the stud…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections [Phase 3]
Open-label Phase III trial evaluating voriconazole for invasive fungal infections has completed, assessing efficacy, safety, and tolerabilit…
-
CLINICAL_TRIALS trial_result · 2008-01-16Clinical Trial Update: A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating caspofungin, liposomal amphotericin B, or the combination for invasive fungal infections in patients after…